Cancer Research Cell Death Mechanisms and Cancer Therapy  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suttmann, H.
Right arrow Articles by Brandau, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suttmann, H.
Right arrow Articles by Brandau, S.
[Cancer Research 66, 8250-8257, August 15, 2006]
© 2006 American Association for Cancer Research


Immunology

Neutrophil Granulocytes Are Required for Effective Bacillus Calmette-Guérin Immunotherapy of Bladder Cancer and Orchestrate Local Immune Responses

Henrik Suttmann1,2, Josef Riemensberger1, Gabriele Bentien1, Dominik Schmaltz1, Michael Stöckle2, Dieter Jocham3, Andreas Böhle4 and Sven Brandau1

1 Division of Immunotherapy, Research Center Borstel, Borstel, Germany; 2 Department of Urology, Saarland University, Homburg/Saar, Germany; 3 Department of Urology, Lübeck University, Lübeck, Germany; and 4 Helios Agnes-Karll Hospital, Bad Schwartau, Germany

Requests for reprints: Sven Brandau, Division of Immunotherapy, Department of Immunology and Cell Biology, Research Center Borstel, Parkallee 1-40, 23845 Borstel, Germany. Phone: 49-4537-188-606; Fax: 49-4537-188-347; E-mail: sbrandau{at}fz-borstel.de.

The role of polymorphonuclear neutrophil granulocytes (PMN) in antitumoral immune responses displays a striking dichotomy. Under inflammatory conditions, PMN may promote tumor growth and progression. In contrast, especially in the context of therapeutic interventions, PMN can exert important antitumor functions. However, until now, the mechanisms of PMN-mediated activation of tumor immunity are poorly defined. Based on a murine model of Bacillus Calmette-Guérin (BCG) immunotherapy of bladder cancer, we provide evidence for a novel immunoregulatory role of this leukocyte subset. PMN immigrate into the bladder after intravesical BCG instillation and depletion of PMN from tumor-bearing mice completely abrogated antitumor efficacy of BCG. PMN stimulated with BCG in vitro as well as PMN isolated from the urine of BCG-treated patients were a major source of the chemokines interleukin-8, growth-related oncogene-{alpha}, macrophage inflammatory protein-1{alpha} and of the inflammatory cytokine migration inhibitory factor. In vitro, BCG-stimulated PMN indirectly induced T-cell chemotaxis via the accessory function of activated monocytes. In vivo, depletion of PMN from BCG-treated mice significantly impaired CD4+ T-cell trafficking to the bladder. These data show that PMN direct the migration of effector cells to the bladder and by this means are indispensable for effective tumor immunotherapy. Thus, our findings provide evidence for a novel early immunoregulatory role of these innate immune cells in local antitumor immunity. (Cancer Res 2006; 66(16): 8250-7)




This article has been cited by other articles:


Home page
Cancer Res.Home page
P. C. Kousis, B. W. Henderson, P. G. Maier, and S. O. Gollnick
Photodynamic Therapy Enhancement of Antitumor Immunity Is Regulated by Neutrophils
Cancer Res., November 1, 2007; 67(21): 10501 - 10510.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Dietrich, R. Billeskov, T. M. Doherty, and P. Andersen
Synergistic Effect of Bacillus Calmette Guerin and a Tuberculosis Subunit Vaccine in Cationic Liposomes: Increased Immunogenicity and Protection
J. Immunol., March 15, 2007; 178(6): 3721 - 3730.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. P. Simons, J. M. Moore, T. J. Kemp, and T. S. Griffith
Identification of the Mycobacterial Subcomponents Involved in the Release of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand from Human Neutrophils
Infect. Immun., March 1, 2007; 75(3): 1265 - 1271.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.